The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been trading flat at around 8,280 points.

Mesoblast (ASX:MSB) has been the most watched on HotCopper so far today on news it’s received seven years of orphan-drug exclusive approval from the U.S. Food and Drug Administration.

Mesoblast has been $1.74.

WA1 Resources (ASX:WA1) has also been trending after Project Lumi’s assay results from resource definition drilling across the west of Luni achieved the best results to date.

WA1 Resources has been $12.28.

And, finally Anson Resources (ASX:ASN) has received the green light to commence a drilling program at its Green River Lithium Project (Project) in south-eastern Utah, USA.

Anson Resources has been 5.3 cents.

More From The Market Online
The Market Online Video

HotCopper Highlights, Week 49: ASX Ltd shoots itself in foot again, NextDC-OpenAI & more

Good afternoon and welcome to HotCopper Highlights, I’m Jon Davidson, in this segment we go through the most viewed and most discussed stocks
ASX concept

ASX announcement outage issue all sorted on Tuesday, but reputational damages remain

More pain for the listed equities in ASX Ltd (ASX:ASX), the share market operator itself, after a Monday morning
A HotCopper-branded graphic image which reads "Insider Trades: Key director trades to watch" in front of an ASX-themed image which has been faded.

Pantoro, WEB, Energy One: All the biggest ASX director trades from the last week

Welcome to HotCopper’s Director Trades column, where we take a look at all the most interesting director transactions from across the past week and break